DNA Script Stock
DNA Script is focused on the manufacturing of synthetic DNA using a proprietary template-free enzymatic technology.
Sign up today and learn more about DNA Script Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About DNA Script Stock
DNA Script is focused on the manufacturing of synthetic DNA using a proprietary template-free enzymatic technology. The company aims at accelerating innovation in life science and technology through rapid, affordable and high quality DNA synthesis. It has the potential to greatly accelerate the development of new therapeutics, sustainable chemical production, improved crops as well as new applications such as data storage.
Funding History
| August 2015 | $0 |
|---|---|
| June 2016 | $2.5M |
| September 2017 | $11.0M |
| April 2018 | $5.5M |
| July 2018 | $2.7M |
Management
Co-founder & CEO
Thomas Ybert
Co-founder & COO
Sylvain Gariel
Co-founder & CTO
Xavier Godron
Press
patents - Apr, 14 2024
Variants of Family a Dna Polymerase and Uses Thereofpatents - Apr, 14 2024
Process for preparing 3'-o-amino-ribonucleotidepatents - Apr, 14 2024
Methods and kits for enzymatic synthesis of g4-prone polynucleotidespatents - Apr, 14 2024
Direct oligonucleotide synthesis on cells and biomoleculespatents - Apr, 14 2024
Efficient product cleavage in template-free enzymatic synthesis of …EquityZen Recognized As:
